- Capital Cube•last monthNeptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q1, 2017 By the Numbers : July 22, 2016
Click here to see latest analysisNeptune Technologies & Bioresources, Inc. reports financial results for the quarter ended May 31, 2016.HighlightsSummary numbers: Revenues of USD 8.66 million, Net Earnings of USD -1.66 million.Gross margins widened from -31.15% to 29.61% compared to the same period last year, operating (EBITDA) margins now -14.97% from -207.49%.Change in operating cash […] (Read more...) The post Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q1, 2017 By the Numbers : July 22, 2016 appeared first on CapitalCube.
- Marketwired•last monthAcasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters Passed at its AGM
Acasti Pharma Inc. of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of hypertriglyceridemia, announced that the nominees listed in its management proxy circular dated June ...
- Marketwired•last month
Neptune Technologies & Bioressources Inc. , announced that the nominees listed in its management proxy circular dated June 14, 2016 were elected as directors of Neptune at its Annual and Special Meeting ...
Neptune Technologies & Bioressources, Inc. (NEPT)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Ask||1.15 x 2000|
|Day's Range||0.97 - 0.99|
|52wk Range||0.86 - 1.38|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-18.66|
|Avg Vol (3m)||76,865|
|Dividend & Yield||0.00 (0.00%)|